5-hydroxybendazac has been researched along with Liver Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campistron, G; Ego, D; Escourrou, J; Houin, G; Ribet, A; Rovei, V; Thiola, A | 1 |
1 other study(ies) available for 5-hydroxybendazac and Liver Cirrhosis
| Article | Year |
|---|---|
The pharmacokinetics of bendazac-lysine and 5-hydroxybendazac, its main metabolite, in patients with hepatic cirrhosis.
Topics: Adult; Aged; Blood Proteins; Female; Humans; Indazoles; Liver Cirrhosis; Male; Middle Aged; Protein Binding; Pyrazoles | 1988 |